期刊文献+

脐血内皮祖细胞移植改善肢体缺血的研究 被引量:23

Transplantation of cord blood endothelial progenitor cells ameliorates limb ischemia
原文传递
导出
摘要 目的 研究脐血来源血管内皮祖细胞 (endothelialprogenitorcells,EPC)的移植对局部缺血的恢复作用。方法 脐血CD133+ 细胞在体外诱导扩增 10~ 14d后 ,收集贴壁梭形细胞 ,检测其内皮细胞特异标志的表达。将荧光标记的贴壁细胞从尾静脉移植到后肢单侧缺血的裸鼠体内。结果从脐血CD133+ 细胞中可诱导出EPC ,表现为表达内皮细胞标志的贴壁细胞。移植后 ,可整合到缺血部位新生血管内。移植EPC后裸鼠缺血后肢的毛细血管密度、血流灌注及坏死程度均较对照组明显改善 :缺血手术后 2周EPC组的缺血肢 /正常肢的血流比由 19 1%± 3 1%恢复为 77 3%± 5 6 % ,而对照组仅恢复为 4 0 6 %± 3 4 % (P <0 0 0 1) ;缺血后肢的完全恢复率由对照组的 1/10上升至 7/12 (P <0 0 5 )。缺血局部VEGFmRNA上调 ,体外VEGF对EPC具有趋化作用。 4h内趋化到下腔的细胞数为817个± 33个 ,而对照组为 4 74个± 6 2个 (P <0 0 5 )。结论 脐血CD133+ 细胞能诱导EPC ,体内移植后能促进肢体缺血的恢复 ,而缺血局部上调的VEGF表达可能是EPC定向整合到缺血局部的关键因素。 Objective To investigate the feasibility of transplanting cord blood CD133 + cells derived endothelial progenitor cells (EPC) in therapeutic vasculogenesis. Methods CD133 + cells from the cord blood of 52 neonates were cultured in fibronectin-coated flask in M199 medium supplemented with 10% fetal bovine serum, 50 ng/ml vascular endothelial growth factor (VEGF), 20 ng/ml interleukin-3 (IL-3) and 50 ng/ml stem cell factor (SCF). The cell markers of spindle-shaped adherent cells were determined with flow cytometry. The left femoral artery, great saphenous artery, iliac circumflex artery, and vein, and muscular branch of 22 Balb/c nude mice were cut to cause limb ischemia. One day after the unilateral ischemic limb surgery half million adherent cells were transplanted into 12 nude mice via tail vein (EPC group) and M199 was injected into the tail veins of 10 nude mice (M199 group). Fluorescence Dil, laser Doppler perfasion imaginer (LDPI) and immunohistochermistry were Laser Doppler perfusion imaginer (LDPI) was used to trace the transplanted cells and monitor the blood perfusion and capillary density of ischemic limbs. The ratio between the blood perfusion of the operated limb and of the non-operated opposite limb was recorded. Two to four mice in each group were killed 4, 7, 14, and 21 days after the operation and the gastrocnemius muscles of bilateral hind limbs were taken to count the number of capillaries. The VEGF mRNA levels of the ischemic and nonischemic limbs were examined with semi-quantitative RT-PCR. Seven days after the operation, fluorescein isothiocyanate (FITC)-binded ulex europaeus agglutinin-1 (UEA-1) was injected via tail vein to 3 EPC group mice. Thirty minutes later, the mice were killed. The heart, lung, liver, spleen and limb muscles were taken and examined with fluorescence microscopy. EPC were added into the upper chamber of Coster Transwell and chemotactic fluids of M199 with or without VEGE were added into the lower chamber. Four hours later the number of EPC in the lower chamber was counted so as to examine t he chemotactic effect of VEGE. Results Numerous cell clustersc; spindle-shaped adherent cells and cord-like structures, developed from the culture of cord blood CD133 + cells. These adherent cells expressed vascular endothelial growth factor receptor 2 (VEGFR-2), VE-cadherin, CD31, von Willebrand factor (vWF) and combined with ulex europaeus agglutinin-1 (UEA-1). Transplanted EPC survived and were incorporated into the capillary networks in the ischemic limbs of nude mice. The ratio between the blood perfusion of the ischemic limb and non-ischenmic limbs was 19.1%±3.1%. Two weeks after the transplantation, the ratio between the blood perfusion of the ischemic limb and non-ischenmic limbs of the EPC group was 77.3%±5.6%, significantly higher than that of the M199 group (40.6%±3.4%, P <0.001). CD31 histochemical staining showed that the density of capillaries in the gastrocnemius muscles of ischemic hind limb was significantly higher 7, 14, and 21 days after operation in the EPC group than in the M199 group ( P <0.05) RT-PCR showed obvious VEGF bands in the ischemic hind limb muscles, but not in the non-ischemic muscles. The number of EPC immigrating into the lower chamber of the Costa transwell was 817±32.5, significantly higher than that of the control group (473.5±61.5, P <0.05). Conclusion Cord blood CD133 + cells derived EPC is a robust cell source for therapeutic neovascularization. Upregulated expression of VEGF may account for the homing of transplanted EPC to ischemic tissue.
出处 《中华医学杂志》 CAS CSCD 北大核心 2003年第16期1437-1441,共5页 National Medical Journal of China
基金 国家重点基础研究发展规划资助项目 (0 0 1CB5 10 1) 国家攀登计划资助项目 (95 专 10 )
关键词 脐血内皮祖细胞移植 肢体缺血 研究 贴壁细胞 Stem cells Transplantation Cord blood
  • 相关文献

参考文献11

  • 1Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med, 2000,6:389-395.
  • 2杨晨,杨仁池,韩忠朝.血管内皮祖细胞的研究进展[J].基础医学与临床,2002,22(5):391-396. 被引量:11
  • 3Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci, 2000, 97:3422-3427.
  • 4Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest, 2000, 105:1527-1536.
  • 5Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med, 2001, 7:430-436.
  • 6Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348:593-600.
  • 7Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 2000, 95:3106-3112.
  • 8Quirici N, Soligo D, Caneva L, et al. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol, 2001, 115:186-194.
  • 9张志华,杨晨,李宗金,钱冠清,杨仁池,丁顺利,韩忠朝.脐血血管内皮祖细胞的分离和诱导分化[J].中国微循环,2003,7(2):78-81. 被引量:11
  • 10Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000, 95:952-958.

二级参考文献39

  • 1[4]Choi K, Kennedy M, Kazarov A, et al. A common precursor for hematopoietic and endothelial cells [J]. Development,1998, 125:725 - 732.
  • 2[5]Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells [J]. EMBO J, 1999, 18: 3964-3972.
  • 3[6]Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart[J]. N Engl J Med, 2002, 346:5 - 15.
  • 4[7]Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells [J]. Blood, 1998, 92: 362-367.
  • 5[8]Lin Y, Weisdorf DJ, Sclovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood [J]. J Clin Invest, 2000, 105:71 - 77.
  • 6[9]Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization[J] . Proc Natl Acad Sci USA, 2000, 97:3422-3427.
  • 7[10]Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of bloodisland formation and vasculogenesis in Flk-1-deficient mice[J]. Nature, 1995 , 376:62 - 66.
  • 8[11]Ziegler BL, Valtieri M, Porada GA, et al. KDR receptor: a key marker defining hematopoietic stem cells [J]. Science,1999, 285:1553 - 1558.
  • 9[12]Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEG-FR-2 and AC133 by circulating human CD34( + ) cells identifies a population of functional endothelial precursors [J].Blood, 2000, 95:952- 958.
  • 10[13]Gehling UM, Ergun S, Schumaeher U, et al. In vitro differentiationof endothelial cells from AC133-positive progenitor cells[J]. Blood, 2000, 95:3106 - 3112.

共引文献20

同被引文献306

引证文献23

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部